Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010. Oleen-Burkey M, Cyhaniuk A, Swallow E BMC Neurol. 2014; 14(1):11. Epub 2014 Jan 14. PMID: 24423119. Abstract CommentRecommendBookmarkWatch